Dexamethasone Sodium Phosphate Ph. Eur.

5 trials HEndocrinology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

0 Recruiting

4 Completed trials

2 Sponsors

14 Countries

Phase III

Phase II

Phase III: 2 Phase II: 3

Indications tested

Plasma cell myeloma 3

Sponsors using this IMP

Sanofi-Aventis Recherche & Developpement 4 University Of Cologne 1

All trials

5 total

Antisense Oligonucleotide Eye Drops against IRS-1 to Optimize Pretransplant Lymphangio-regression Prior to High-Risk Keratoplasty (Olisens-P… Pending

2025-522099-10-00 Phase II 1 country University Of Cologne
International treatment-extension study in adult participants with multiple myeloma and who have derived clinical benefit from isatuximab Ended

2023-507180-19-00 Phase II 7 countries Sanofi-Aventis Recherche & Developpement
A study to investigate subcutaneous isatuximab in combination with carfilzomib and dexamethasone in adult participants with relapsed and/or … Ended

2023-508870-27-00 Phase II 3 countries Sanofi-Aventis Recherche & Developpement
Isatuximab in combination with lenalidomide and dexamethasone in high-risk smoldering multiple myeloma Ended

2023-507419-37-00 Phase III 11 countries Sanofi-Aventis Recherche & Developpement
A study to investigate the clinical benefit of isatuximab in combination with bortezomib, lenalidomide and dexamethasone in adults with newl… Ended

2024-514417-34-00 Phase III 11 countries Sanofi-Aventis Recherche & Developpement

Showing 1–5 of 5 trials

← All drugs A–Z